To enhance monitoring, we suggest that AFP surveillance officers in areas where Aedes aegypti is present should immediately notify the detection of clusters of AFP cases diagnosed as Guillain-Barré syndrome, or if there is an increase in the number of AFP/Guillain-Barré syndrome cases above the previous baseline for the area. This evidence concerns the gene AFP and Guillain-Barre syndrome.